title: [Erythromycin: an alternative in conservative management of Ogilvie syndrome].
authors.forename: B
authors.initials: B
authors.lastname: Acea Nebril
authors.forename: M
authors.initials: M
authors.lastname: Madriñán González
authors.forename: P
authors.initials: P
authors.lastname: Valiño
authors.forename: B
authors.initials: B
authors.lastname: Blanco Freire
authors.forename: D
authors.initials: D
authors.lastname: Freire Rodríguez
authors.forename: C
authors.initials: C
authors.lastname: Gómez Freijoso
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003112:Colonic Pseudo-Obstruction / Q000188:drug therapy*; D004917:Erythromycin / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D013997:Time Factors
chemical_list: D000900:Anti-Bacterial Agents; D004917:Erythromycin
vernacular_title: Eritromicina: una alternativa para el manejo conservador del síndrome de Ogilvie.